Clinical and Blood Parameters in COVID-19 Patients with Alcohol Use Disorder

A pilot study dataset compares 63 patients with alcohol use disorder, split into groups with and without symptomatic COVID-19. The data includes clinical assessments for alcohol use severity and cognition, alongside inflammatory, biochemical, and lipid blood parameters, measured at two time points six months apart. The dataset was authored by Lea Kozina and shared on figshare under a CC-BY-4.0 license.

Use Cases

• Modeling cognitive function changes based on COVID-19 history and alcohol relapse status.
• Analyzing relationships between inflammatory markers like CRP and time since COVID-19 recovery.
• Investigating longitudinal patterns in lipid profiles, such as total cholesterol, in patients with alcohol use disorder.

Strengths

• Data from 63 participants meeting rigorous inclusion criteria.
• Includes validated clinical instruments (AUDIT, MoCA, PACS) and multiple blood parameter types.
• Longitudinal design with measurements taken six months apart.

Limitations

• The dataset is small (63 participants), limiting statistical power.
• Column-level documentation is absent; field semantics must be inferred after download.
• The sample is specific to a clinical study, which may limit generalizability.

Provenance

Source

Lea Kozina via figshare.

Collection Method

Clinical study using questionnaires, interviews, and blood tests.

Freshness

Last updated 2026-04-23 05:27:09; freshness should be verified.